|  | Outpatients (17) | Remitted patients (18) | Between-group comparison |
---|---|---|---|---|
p | ||||
BPRS Total | Pre | 1.43 (0.59) | - | - |
Post | 0.27 (0.47) | 0.43 (0.38) | .273 | |
Follow-up2 | 1.47 (0.69) | 0.90 (0.67) | .021 | |
Repeated measures ANOVA | p | <.0013 | <.0014 | - |
Contrasts | Pre-Post: <.001 | - | - | |
Pre-FU: .816 | ||||
Post-FU: <.001 | ||||
BPRS Positive | Pre | 1.70 (1.05) | - | - |
Post | 0.36 (0.63) | 0.32 (0.51) | 0.823 | |
Follow-up2 | 1.81 (1.47) | 0.89 (1.15) | .054 | |
Repeated measures ANOVA | p | <.0015 | .0276 | - |
Contrasts | Pre-Post: <.001 | - | - | |
Pre-FU: .791 | ||||
Post-FU: .001 | ||||
BPRS Negative | Pre7 | 1.56 (0.83) | - | - |
Post | 0.32 (0.68) | 0.37 (0.46) | .812 | |
Follow-up2 | 2.89 (1.71) | 1.42 (1.13) | .024 | |
Repeated measures ANOVA | p | <.0018 | <.0019 | - |
Contrasts | Pre-Post: <.001 | - | - | |
Pre-FU: .022 | ||||
Post-FU: <.001 | ||||
BPRS Depression | Pre7 | 2.06 (1.43) | - | - |
Post | 0.34 (0.70) | 0.64 (0.47) | .144 | |
Follow-up2 | 0.50 (0.79) | 0.65 (0.60) | .562 | |
Repeated measures ANOVA | p | <.00110 | .97411 | - |
Contrasts | Pre-Post: <.001 | - | - | |
Pre-FU: <.001 | ||||
Post-FU: .551 | ||||
BPRS Activation | Pre12 | 1.44 (0.72) | - | - |
Post13 | 0.49 (0.58) | 0.38 (0.52) | .684 | |
Follow-up2 | 0.90 (1.12) | 0.70 (0.94) | .595 | |
Repeated measures ANOVA | p | .00714 | .44415 | - |
Contrasts | Pre-Post: <.001 | Â | - | |
Pre-FU: .051 | ||||
Post-FU: .120 |